September 3 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus said that its fully-owned subsidiary Salus, Veletrgovina signed an agreement to buy local counterpart Farmadent from six local municipalities for 8.46 million euro ($9.8 million), reviving a deal first pursued in 2023.